The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis

Adjuvant chemotherapy after pancreatoduodenectomy for pancreatic cancer is currently considered standard of care. In this nationwide study, we investigated which characteristics determine the likelihood of receiving adjuvant chemotherapy and its effect on overall survival. The data were obtained fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakens, Maikel J., van der Geest, Lydia G., van Putten, Magreet, van Laarhoven, Hanneke W., Creemers, Geert‐Jan, Besselink, Marc G., Lemmens, Valery E., de Hingh, Ignace H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083735/
https://www.ncbi.nlm.nih.gov/pubmed/27671746
http://dx.doi.org/10.1002/cam4.921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083735/
https://www.ncbi.nlm.nih.gov/pubmed/27671746
http://dx.doi.org/10.1002/cam4.921

Ejemplares similares